Amprius Technologies, Inc. — Form 8-K Summary
Reporting event: The filing reports a material financing agreement entered into on September 27, 2022; the Form 8-K was signed on September 28, 2022. No operating or quarterly financial results are included.
Business Context and Transaction
Amprius Technologies entered into a Common Stock Purchase Agreement and Registration Rights Agreement with B. Riley Principal Capital II, LLC. The arrangement is an equity financing facility under which the company may, but is not obligated to, sell newly issued common stock to B. Riley over a 24-month period following effectiveness of the related registration statement.
- Maximum aggregate gross proceeds: up to $200 million, subject to applicable conditions and share limitations.
- Purchases may occur through regular and intraday VWAP transactions at prices based on market trading prices, generally with a fixed discount to the applicable VWAP.
- The company controls the timing and amount of sales; no shares beyond the commitment shares are required to be sold.
- Commencement is conditional on satisfaction of specified conditions, including SEC effectiveness of the resale registration statement and filing of a final prospectus.
Financial Metrics, Liquidity, and Capitalization
| Item | Reported information |
|---|---|
| Revenue, profit, margins, and cash flow | The filing text does not provide a clear value; no operating results are reported. |
| Debt and liquidity | The filing text does not provide a clear value for debt, cash, liquidity, or cash-burn metrics. |
| Potential financing proceeds | Up to $200 million in gross proceeds, subject to conditions, market activity, and share-cap limitations. |
| Commitment shares | 84,793 shares were issued upon execution. An additional 84,793 shares may be issued after B. Riley has paid aggregate cash proceeds of $100 million for purchased shares. |
| Legal-fee reimbursement | Up to $100,000 at or before execution, plus up to $7,500 per fiscal quarter, for B. Riley’s legal fees and disbursements. |
Material Changes and Dilution Considerations
- The initial 84,793 commitment shares were issued as consideration for B. Riley’s purchase commitment and represent immediate equity dilution.
- Additional dilution could result from future stock sales and the potential issuance of the additional 84,793 commitment shares.
- The NYSE Exchange Cap generally limits issuance under the agreement to 16,825,366 shares, or 19.99% of outstanding common stock at execution, subject to exceptions and possible stockholder approval.
- B. Riley and its affiliates may not beneficially own more than 4.99% of the company’s outstanding common stock as a result of purchases.
- The facility does not establish a fixed share price or guaranteed proceeds; the number of shares issued will depend on market prices, trading volume, company elections, and applicable limitations.
Outlook, Conditions, and Risks
- There is no management earnings guidance or operating outlook in the filing.
- Funding availability depends on the registration statement becoming effective, continued satisfaction of purchase conditions, the common stock remaining listed on an eligible exchange, and the stock price meeting applicable thresholds.
- VWAP purchases generally require the prior trading-day closing price to be at least $1.00, subject to adjustments under the agreement.
- The company may terminate the agreement after commencement with 10 trading days’ notice and no stated termination penalty. B. Riley may also terminate upon specified events.
- The agreement restricts certain variable-rate transactions and similar equity lines during its term, subject to exceptions.
- The facility automatically terminates upon specified events, including completion of $200 million in purchases, loss of eligible exchange listing, or certain bankruptcy-related events.
- Actual proceeds may be substantially below the maximum because sales are optional and depend on market conditions and the company’s financing decisions.
Key Facts for Investors to Verify
- Whether and when the SEC declared the resale registration statement effective and the facility commenced.
- The actual number of shares sold to B. Riley, prices and discounts applied, gross proceeds received, and remaining facility capacity.
- Whether the additional 84,793 commitment shares became issuable after cumulative proceeds reached $100 million.
- Current shares outstanding, remaining NYSE Exchange Cap capacity, and the effect of any required stockholder approval.
- Subsequent filings describing use of proceeds, cash runway, dilution, and any termination or modification of the financing facility.